该病例也被心衰领域国际知名期刊《ESC Heart Failure》正式刊登于2023年1月刊中,体现了国际学者对这一病例临床意义的充分认可,为TEER治疗非梗阻性HCM合并严重MR患者的有效性和可行性补充了来自中国的临床证据。 手术的主要术者,同时也是文章...
今年,在阿姆斯特丹举行的欧洲心脏病学会(ESC)大会举办了9场热线会议,讨论了心血管药物治疗领域一些最受期待且可能改变实践的临床试验。 Heart failure (HF) was the focus of the congress, accounting for nearly a third of the ...
可以看出国人文章占比很高,投稿难度较低。 总的来说,ESC Heart Failure的影响因子为3.8,在心脏病学和心血管医学领域中影响力和排名适中,年发文量为473篇,审稿速度平均5个月,2023年国人文章占比24%,投稿难度属于中等。 时间急,投稿总被拒? 扫码咨询,最快2-4个月录用 21+杂志社内部合作,官网直投优先录用 定制...
The 2023 update of the European Society of Cardiology (ESC) guidelines recommends (class IA) the administration of sodium-glucose transporter 2 inhibitors (SGLT2i) also for patients with heart failure with preserved ejection fraction (HFpEF) and mildly reduced EF (HFmrEF). Thus, SGLT2i are the...
ESC心力衰竭 ISSN:2055-5822 是否OA:No ESSN:2055-5822 国际简称:ESC HEART FAIL 3区中科院分区 3.407影响因子 2024年SCI期刊影响因子出炉获取相关优质资源精准匹配期刊 SCI优质选题 严选服务 安全可靠 四区 质量保证 保密协议 化学工程/制药,医学 了解详情...
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF),1there have been several randomized controlled trials that should change patient management ahead of the next scheduled full guidelines. This 2023 Focused Update addresses changes ...
事实上,LVEF并不是一种准确的危险分层方法,更新颖的超声心动图指标,如整体纵向应变(GLS)将有助于更准确地预测结果。近日,伊朗设拉子西拉医科大学医学院心血管内科Armin Attar教授等人发表在ESC Heart Failure上的一项研究对接受ICD的缺血性心脏病或扩张型心肌病(DCM)患者室性心动过速(VT)/心室纤颤(VFs)的发生率...
2“This focused update incorporates the latest evidence-based treatments into state-of-the-art management recommendations with the aim of improving the outcome of patients with heart failure.” References: McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for...
NYHA heart failure classes are as follows [2] : Class I: No limitation of physical activity Class II: Slight limitation of physical activity, in which ordinary physical activity leads to fatigue, palpitation, or dyspnea; the person is comfortable at rest Class III: Marked limitation of ...
Congestive heart failure, Hypertension, Age, Diabetes, Stroke or TIA-Vascular disease 充血性心力衰竭、高血压、年龄、糖尿病、中风或TIA血管疾病 Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition ...